Global disparities and future directions in cardio-oncology training: an international survey of cardiology trainees from the international cardio-oncology society [0.03%]
全球心脏病学-肿瘤学培训的差异及未来发展方向：国际心脏科培训医师调查报告（国际心脏病学-肿瘤学协会发起）
James M Wilson,Joshua Lushington,Rhys Gray et al.
James M Wilson et al.
Introduction: Cardio-oncology has emerged as a vital subspecialty as the population of cancer patients with cardiovascular comorbidities and treatment-related cardiotoxicities grows. Despite its clinical importance, conce...
Coronary artery calcification burden in cancer vs. non-cancer populations: a systematic review and meta-analysis [0.03%]
癌症与非癌症人群冠状动脉钙化负担的系统评价和meta分析
James Hua Wang,Jacky Chen,Joshua Wong et al.
James Hua Wang et al.
Association of PCSK9 inhibitors versus statins with cancer incidence: a target trial emulation [0.03%]
PCSK9抑制剂与他汀类药物的癌症发生率比较：目标试验模拟研究
Chi-Hsien Huang,Shiow-Ing Wang,Frank S Fan et al.
Chi-Hsien Huang et al.
Cardiomyocyte overexpression of microRNA-210 mitigates apoptotic cell death induced by doxorubicin [0.03%]
心肌细胞过度表达微小RNA-210可减轻多柔比星诱导的凋亡性细胞死亡
Johan Guthormsen,Mikal Solstad Øiaas,Mido Magdi Allam et al.
Johan Guthormsen et al.
Sustained mesenchymal reprogramming of endothelial cells after completion of chemotherapy [0.03%]
化疗结束后内皮细胞的间充质重编程持续存在
Kass Sjostrom,Shixin Tao,Melissa S Cobb et al.
Kass Sjostrom et al.
Cardiovascular disease is the prevailing cause of death among cancer survivors. Remarkable increase in cardiac disease burden in this group is likely due to the effects of cancer itself and, especially, cardiotoxic cancer treatments. Of the...
Cardiovascular impacts of combination cancer therapies in Africa: challenges and solutions [0.03%]
非洲联合癌症疗法的心血管影响：挑战与对策
Boluwatife Samuel Fatokun,Pascal Mathew Okorobe,Omosola Lydia Bolarin et al.
Boluwatife Samuel Fatokun et al.
Background: In Africa, deaths from non-infectious causes, including cancer, have been rising. In 2022, over a million new cancer cases were reported, and projections indicate that this number could double by 2040 without ...
Heart failure related cardiotoxicity in breast cancer survivors: a scoping review [0.03%]
乳腺癌幸存者的心力衰竭相关心脏毒性：系统综述
Pinyadapat Vacharanukrauh,Kyle J Miller,Sheikh M Alif et al.
Pinyadapat Vacharanukrauh et al.
Background: Breast cancer is the most common malignancy among women globally and the second most frequently diagnosed cancer overall, with 2.3 million new cases reported in 2022. While advances in therapy have substantial...
Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma [0.03%]
霍奇金淋巴瘤患者血浆蛋白质组与心脏毒性的相关性探索研究
Johan Mattsson Ulfstedt,Ragnhild Risebro,Eva Freyhult et al.
Johan Mattsson Ulfstedt et al.
Cardiogenic shock in cancer: differences in use of temporary mechanical circulatory support, invasive hemodynamic assessment and patient outcomes [0.03%]
癌症心源性休克患者临时机械循环支持、侵入性血流动力学评估及预后的差异
Sara Diaz Saravia,Vincent Torelli,Maninderjit Ghotra et al.
Sara Diaz Saravia et al.
Real-world management and outcomes of venous thromboembolism in patients with cancer and limited life expectancy in the direct oral anticoagulant era: insights from the COMMAND VTE Registry-2 [0.03%]
直接口服抗凝血剂时代晚期恶性肿瘤患者静脉血栓栓塞症的管理及结局：COMMAND VTE登记研究第二部分启示
Takahiro Kuno,Norimichi Koitabashi,Yugo Yamashita et al.
Takahiro Kuno et al.